Vector Design for Improved DNA Vaccine Efficacy, Safety and Production

Vaccines
James A Williams

Abstract

DNA vaccination is a disruptive technology that offers the promise of a new rapidly deployed vaccination platform to treat human and animal disease with gene-based materials. Innovations such as electroporation, needle free jet delivery and lipid-based carriers increase transgene expression and immunogenicity through more effective gene delivery. This review summarizes complementary vector design innovations that, when combined with leading delivery platforms, further enhance DNA vaccine performance. These next generation vectors also address potential safety issues such as antibiotic selection, and increase plasmid manufacturing quality and yield in exemplary fermentation production processes. Application of optimized constructs in combination with improved delivery platforms tangibly improves the prospect of successful application of DNA vaccination as prophylactic vaccines for diverse human infectious disease targets or as therapeutic vaccines for cancer and allergy.

References

Jul 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·E Goldstein, K Drlica
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·T C WuD M Pardoll
Sep 1, 1999·Gene Therapy·F SoubrierJ Crouzet
Jan 15, 2000·The Journal of Biological Chemistry·G L LukacsA S Verkman
Mar 14, 2000·The Journal of Biological Chemistry·E L ZechiedrichN R Cozzarelli
Mar 29, 2001·Genes & Development·R W DeiblerE L Zechiedrich
Jul 27, 2001·Proceedings of the National Academy of Sciences of the United States of America·S BauerG B Lipford
Nov 16, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·J HartikkaM Sawdey
Jul 13, 2002·Science·William G FairbrotherChristopher B Burge
Jan 21, 2003·Journal of Bacteriology·Yazmid Reyes-DomínguezM Carmen Gómez-Eichelmann
Jun 26, 2003·Nucleic Acids Research·Michael Zuker
Apr 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Reinhold SchirmbeckJörg Reimann
Aug 31, 2006·Applied Microbiology and Biotechnology·Kristala L Jones PratherJerrell W Herod
Sep 7, 2007·Biotechnology Journal·Jürgen MairhoferReingard Grabherr
Nov 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Avi-Hai HovavNorman L Letvin
Jan 26, 2008·Nature Reviews. Cancer·Jason RiceFreda K Stevenson
Mar 8, 2008·Expert Review of Vaccines·Shan LuJill M Grimes-Serrano
Mar 11, 2008·Molecular Biotechnology·Juergen Mairhofer, Reingard Grabherr
Apr 29, 2008·Nature Biotechnology·Stephen C HydeDeborah R Gill
Jun 7, 2008·Human Vaccines·Cevayir CobanKen J Ishii
Sep 11, 2008·Nature Reviews. Genetics·Michele A Kutzler, David B Weiner
Nov 4, 2008·Trends in Biotechnology·Philip R DormitzerRino Rappuoli
Jan 1, 2007·Recent Patents on Biotechnology·Aaron E Carnes, James A Williams
Feb 24, 2009·Biotechnology Advances·James A WilliamsClague P Hodgson

❮ Previous
Next ❯

Citations

Feb 11, 2016·Jundishapur Journal of Microbiology·Mohammad Amin BehzadiMazyar Ziyaeyan
Jul 24, 2015·Acta Parasitologica·Halina Wedrychowicz
Jun 13, 2017·Human Vaccines & Immunotherapeutics·John J SuschakConnie S Schmaljohn
Jun 15, 2017·Human Vaccines & Immunotherapeutics·Ingrid KarlssonAnders Fomsgaard
Mar 24, 2018·Medical Sciences : Open Access Journal·Valentina Yurina
Dec 7, 2017·Oncoimmunology·Stefano PieriniLorenzo Galluzzi
Dec 28, 2018·Biotechnology & Genetic Engineering Reviews·Armando Tejeda-MansirPatricia Guerrero-Germán
Mar 19, 2020·Molecular Biotechnology·Shamini ChelliahSalmah Ismail
Feb 6, 2020·Vaccines·Jason GummowBranka Grubor-Bauk
Jul 25, 2018·Frontiers in Immunology·Leo Yi Yang LeeAeron C Hurt
Mar 12, 2020·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Ami PatelDavid B Weiner
Jul 10, 2018·FEMS Microbiology Letters·Tania Selas CastiñeirasDaniel C Smith
Dec 4, 2019·Expert Review of Vaccines·Iván Del Moral-Sánchez, Kwinten Sliepen
Mar 25, 2017·Nanomaterials·Fatin M Nawwab Al-DeenMagdalena Plebanski
Dec 12, 2018·Biotechnology Journal·Zoltán KisCleo Kontoravdi
Aug 28, 2020·F1000Research·Wern Hann NgSuresh Mahalingam
Sep 8, 2020·Angewandte Chemie·Christoph O FranckLjiljana Fruk
Feb 12, 2021·Viruses·Anders Fomsgaard, Margaret A Liu
Nov 19, 2020·Immunology·Elham FakhrAngel Cid-Arregui
Jan 11, 2021·Advanced Drug Delivery Reviews·Deborah PushparajahRoderick A Slavcev
Feb 12, 2017·Pharmacology & Therapeutics·Christopher D ZahmDouglas G McNeel
Jun 8, 2021·Molecular Therapy. Methods & Clinical Development·Nathan P Sweeney, Conrad A Vink
Aug 10, 2021·Bioelectrochemistry·Carly BoyeAnna Bulysheva
Aug 19, 2021·Expert Review of Vaccines·Subhadip ChoudhuriNisha Jain Garg
Nov 26, 2021·Inquiry : a Journal of Medical Care Organization, Provision and Financing·Fang PengYifeng Zhou
Oct 27, 2021·Journal of Veterinary Science·Lalu UnsunnidhalAsmarani Kusumawati

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
transfect
PCR
environmental stress

Software Mentioned

HyperGRO
GeneArt GeneOptimizer Process
BLASTN
mfold

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

Methods in Molecular Biology
Sandra IuresciaMonica Rinaldi
Pharmaceutical Patent Analyst
Kathleen L Hefferon
Current Opinion in Immunology
Niranjan Y Sardesai, David B Weiner
© 2021 Meta ULC. All rights reserved